Cancer Genomics - Cancer PHGKB -|Specific PHGKB|Cancer|PHGKB|Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

From NIH National Cancer Institute Web Sites

---

• Approaches to Blue Ribbon Panel Recommendations: The Case of Lynch Syndrome  
• Approval of Osimertinib and Necitumumab Increases Lung Cancer Treatment Options  
• Aspirin to Reduce Cancer Risk  
• Bringing Precision to Screening for Cancer  
• Cancer Control P.L.A.N.E.T. portal  
   Cancer Control P.L.A.N.E.T. portal provides access to data and resources that can help planners, program staff, and researchers design, implement and evaluate evidence-based cancer control programs.
• Cancer Moonshot Blue Ribbon Panel Report  
• Cancer Moonshot℠  
• CCG Funding Opportunities  
  Biospecimen Processing and Storage
• Checking In on Cancer Checkpoint Inhibitors  
• Divide and Conquer: The Molecular Diagnosis of Cancer  
• DNA Misfolding Revealed as Novel Oncogenic Mechanism  
• Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches  
• Establishing UniversalLynch Syndrome Screening in the Community  
• FDA Approves Alectinib for ALK-Positive Non-Small Cell Lung Cancer  
• For Some Children with Cancer, Genomic Information May Help Guide Treatment Decisions  
• Gene Fusion May Drive Rare Childhood Brain Tumor  
• Genetics of Skin Cancer (PDQ®)–Health Professional Version  
• How Genomics Is Shaping Precision Medicine in Oncology  
• Insights from the Precision Public Health Summit  
• Kidney (Renal Cell) Cancer—Patient Version  
• Metabolomics in Population-Based Research  
• NCI-DOE Collaboration Paving Way for Large-Scale Computational Cancer Science  
• NCI-MATCH: A Status Report and Future Directions  
• Precision Medicine and Population Health  
  Cross Cutting Research Area in the NCI Division of Cancer Control and Population Sciences
• Prevention and Early Detection for Hereditary Cancer Syndromes  
  NCI website with resources, events and funding
• Researchers report initial feasibility of identifying patients who are exceptional responders to cancer therapy  
• Stomach (Gastric) Cancer Prevention (PDQ®)–Health Professional Version  
• Targeted Photoimmunotherapy Approach for Cancer Moves Forward  
• The Cancer Genome Atlas  
• Thyroid Cancer—Patient Version  
• Using Gene Expression to Diagnose Lung Cancer More Accurately  
• With FDA Approval, Gefitinib Returns to U.S. Market for Some Patients with Lung Cancer